Skip to main navigation Skip to search Skip to main content

Effect of rosuvastatin and atorvastatin on CRP levels in patients with type 2 diabetes: Results from the Andromeda Study

    Research output: Chapter in Book/Conference proceeding › Conference contribution

    Original languageEnglish
    Title of host publicationArtherosclerosis Supplements
    Volume6
    Publication statusPublished - 2005

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this